leisure time -WSS

leisure time

author：Wikipedia 2025-09-29 22:51:16 - browse：85

JOSEPH PREZIOSO/AFP via Getty Images

LONDON — The U.K.’s cost-effectiveness watchdog said Thursday it is not yet recommending Vertex’s CRISPR-based therapy for sickle cell disease, saying in draft guidance it has questions about the medicine’s lasting benefits for patients.

U.K. regulators approved the therapy, known as Casgevy or exa-cel, last year, granting it the world’s first authorization for any CRISPR-based medicine. But observers have been watching to see how the U.K.’s National Institute for Health and Care Excellence, as well as similar agencies in European countries, would view the pricey, one-time therapy. NICE needs to recommend the therapy for it to be offered in the National Health Service.

In the U.S., Casgevy has a list price of $2.2 million. It was developed by Vertex in partnership with CRISPR Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： DOJ, FTC to increase scrutiny of all types of health care mergers

WSS

Medical experts are missing from AI regulatory conversations

Too many hospitalized Covid

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Why some people catch Covid but never get sick

Stanford updates investigation of president’s past research

Websites selling Wegovy, Zepbound ingredients targeted by FDA

hotspot

leisure time

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Doctors on social media are being harassed and cyberbullied

How one medical school became remarkably diverse

Stanford updates investigation of president’s past research

At least 13 dead in Texas as scorching temps continue

Doctors on social media are being harassed and cyberbullied

Continuity nursing helped my family in our darkest PICU moments

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

In Memoriam: Notable people who died in 2023

Having children helps parents live longer, especially after age 80

Wikipedia

Bernie Sanders gets little from pharma CEOs on drug prices

Juul documents reveal insider tactics on political lobbying

Latigo launches with $135 million for Vertex

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Artificial intelligence use in health care faces greater scrutiny in 2024

focus

entertainment

explore

leisure time